NIH-funded research R21 grant

Investigating how cannabinoids may increase the risk of testicular cancer.

Official title: Cannabinoids as an environmental risk factor of testicular cancer: Assessment using cell culture models of human and mouse primordial germ cells and by exposure of pregnant mice

Funded at Massachusetts General Hospital · NIH-11089391 · Data updated 2026-11-12

This study is looking into how exposure to cannabis during pregnancy might affect the development of testicular cancer in boys, using lab models to see how substances like THC and CBD could impact the growth of important cells in the testicles.

More Testicular Cancer research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 15, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$208,750
NIH project number5R21DA059789-02
Project IDNIH-11089391 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include young men aged 15 to 44, particularly those with a family history of testicular cancer or those concerned about environmental risk factors.

Less likely to help

Patients who are not male or who do not fall within the age range of 15 to 44 years may not receive benefit from this research.

What this research studies

This research explores the potential link between cannabinoid exposure, particularly during pregnancy, and the development of testicular cancer in males. By using cell culture models of human and mouse primordial germ cells, the study aims to understand how cannabinoids like THC and CBD may disrupt normal germ cell development. The researchers will assess the effects of these substances on germ cells and testicular somatic cells to uncover the mechanisms behind any observed cancer risk. This work is crucial for understanding environmental factors that may contribute to testicular cancer.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and prevention strategies for testicular cancer linked to cannabinoid exposure.

How similar studies have gone: Previous epidemiological studies have indicated a significant link between marijuana use and increased testicular cancer risk, suggesting that this research builds on established findings.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Shioda, Toshihiro — Massachusetts General Hospital
  • Study coordinator: Shioda, Toshihiro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.